SG11202107310RA - Defensin fragments for use in therapy or prophylaxis - Google Patents
Defensin fragments for use in therapy or prophylaxisInfo
- Publication number
- SG11202107310RA SG11202107310RA SG11202107310RA SG11202107310RA SG11202107310RA SG 11202107310R A SG11202107310R A SG 11202107310RA SG 11202107310R A SG11202107310R A SG 11202107310RA SG 11202107310R A SG11202107310R A SG 11202107310RA SG 11202107310R A SG11202107310R A SG 11202107310RA
- Authority
- SG
- Singapore
- Prior art keywords
- prophylaxis
- therapy
- defensin
- fragments
- defensin fragments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102019100230 | 2019-01-07 | ||
| DE102019108626 | 2019-04-02 | ||
| PCT/EP2020/050186 WO2020144166A1 (en) | 2019-01-07 | 2020-01-07 | Defensin fragments for use in therapy or prophylaxis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202107310RA true SG11202107310RA (en) | 2021-08-30 |
Family
ID=69167795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202107310RA SG11202107310RA (en) | 2019-01-07 | 2020-01-07 | Defensin fragments for use in therapy or prophylaxis |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220064217A1 (en) |
| EP (1) | EP3908305A1 (en) |
| JP (1) | JP7479381B2 (en) |
| KR (1) | KR20210126585A (en) |
| CN (1) | CN113453701A (en) |
| AU (1) | AU2020207527A1 (en) |
| BR (1) | BR112021013434A2 (en) |
| CA (1) | CA3125689A1 (en) |
| MX (1) | MX2021008249A (en) |
| SG (1) | SG11202107310RA (en) |
| WO (1) | WO2020144166A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114456232B (en) * | 2021-11-09 | 2023-09-29 | 中国科学院动物研究所 | Medicine for inhibiting edible obesity and polypeptide used by medicine |
| KR20230122899A (en) * | 2022-02-15 | 2023-08-22 | 주식회사 나이벡 | Peptide having antibacterial, antiinflammation or tissue regeneration and uses thereof |
| CN117304297B (en) * | 2023-10-18 | 2024-05-31 | 河南大学 | Recombinant human alpha-defensin 5 and preparation method and application thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007081486A2 (en) | 2005-12-15 | 2007-07-19 | Ventria Bioscience | Oral administration of defensins to treat intestinal diseases |
| SG11201805954WA (en) * | 2016-01-26 | 2018-08-30 | Defensin Therapeutics Aps | Methods for modulating intestinal microbiota |
| AU2017258242B2 (en) | 2016-04-29 | 2024-04-04 | Novozymes A/S | Treatment of liver, biliary tract and pancreatic disorders |
| AU2017376400A1 (en) | 2016-12-13 | 2019-06-20 | Novozymes A/S | Methods for treating inflammatory conditions of the lungs |
-
2020
- 2020-01-07 CN CN202080015217.3A patent/CN113453701A/en active Pending
- 2020-01-07 US US17/420,155 patent/US20220064217A1/en active Pending
- 2020-01-07 CA CA3125689A patent/CA3125689A1/en active Pending
- 2020-01-07 WO PCT/EP2020/050186 patent/WO2020144166A1/en active Application Filing
- 2020-01-07 EP EP20700766.7A patent/EP3908305A1/en active Pending
- 2020-01-07 MX MX2021008249A patent/MX2021008249A/en unknown
- 2020-01-07 JP JP2021539592A patent/JP7479381B2/en active Active
- 2020-01-07 AU AU2020207527A patent/AU2020207527A1/en active Pending
- 2020-01-07 BR BR112021013434-4A patent/BR112021013434A2/en not_active Application Discontinuation
- 2020-01-07 KR KR1020217025114A patent/KR20210126585A/en unknown
- 2020-01-07 SG SG11202107310RA patent/SG11202107310RA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2021008249A (en) | 2021-10-13 |
| EP3908305A1 (en) | 2021-11-17 |
| JP7479381B2 (en) | 2024-05-08 |
| CN113453701A (en) | 2021-09-28 |
| JP2022517764A (en) | 2022-03-10 |
| AU2020207527A1 (en) | 2021-08-19 |
| CA3125689A1 (en) | 2020-07-16 |
| WO2020144166A1 (en) | 2020-07-16 |
| US20220064217A1 (en) | 2022-03-03 |
| BR112021013434A2 (en) | 2021-10-19 |
| KR20210126585A (en) | 2021-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282663A (en) | Bt1718 for use in treating cancer | |
| SG11202107310RA (en) | Defensin fragments for use in therapy or prophylaxis | |
| GB201900702D0 (en) | Therapy | |
| ZA202007955B (en) | Ccr5 inhibitor for use in treating cancer | |
| GB201702160D0 (en) | Inhibitors for use in therapy | |
| IL284981A (en) | Semaphorin-4d antagonists for use in cancer therapy | |
| IL288237A (en) | Combination therapy | |
| IL285538A (en) | Combination therapies for use in treating cancer | |
| ZA201907017B (en) | Combination therapy for use in treating retroviral infection | |
| GB201821147D0 (en) | Mirna for use in therapy | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| IL283687A (en) | Usp19 inhibitors for use in therapy | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| EP3810181A4 (en) | Lubricin for use in wound healing | |
| GB201906864D0 (en) | Combination therapy | |
| EP3965793C0 (en) | Peptides for use in therapy or prophylaxis of herpesviridae-infections | |
| GB201918539D0 (en) | Compounds for use in treatment and prophylaxis | |
| ZA202200731B (en) | Combination therapy | |
| GB201913816D0 (en) | Novel compositions having use in therapy | |
| GB201919301D0 (en) | Combination therapy | |
| GB201917254D0 (en) | Combination therapy | |
| GB201914006D0 (en) | Combination Therapy | |
| GB201910473D0 (en) | Combination therapy | |
| GB201908225D0 (en) | Combination therapy | |
| GB201908233D0 (en) | Combination therapy |